Taiwan Biomaterial Co., Ltd. (TPEX:6649)
39.65
-0.45 (-1.13%)
Apr 20, 2026, 1:22 PM CST
Taiwan Biomaterial Market Cap
Taiwan Biomaterial has a market cap or net worth of 1.65 billion as of April 20, 2026. Its market cap has decreased by -4.04% in one year.
Market Cap
1.65B
Enterprise Value
1.34B
Revenue
220.40M
Ranking
n/a
PE Ratio
28.00
Stock Price
39.65
Market Cap Chart
Since August 29, 2017, Taiwan Biomaterial's market cap has decreased from 2.34B to 1.65B, a decrease of -29.64%. That is a compound annual growth rate of -3.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 1.65B | -15.70% |
| Dec 31, 2025 | 1.95B | 35.96% |
| Dec 31, 2024 | 1.44B | 9.27% |
| Dec 29, 2023 | 1.31B | -9.80% |
| Dec 30, 2022 | 1.46B | 78.08% |
| Dec 30, 2021 | 818.40M | -16.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| A Plus Biotechnology | 2.49B |
| Applied BioCode | 2.34B |
| Wellell | 2.27B |
| OK Biotech | 1.89B |
| Diamond Biotechnology | 1.56B |
| Cowealth Medical Holding | 1.48B |
| Bioptik Technology Incorporation | 1.45B |
| PlexBio | 1.35B |